Article
The Emerging Roles of the Metabolic Regulator G6PD in Human Cancers
7 Dec 2023
Abstract excerpt
Metabolic reprogramming, especially reprogrammed glucose metabolism, is a well-known cancer hallmark related to various characteristics of tumor cells, including proliferation, survival, metastasis, and drug resistance. Glucose-6-phosphate dehydrogenase (G6PD) is the first and rate-limiting enzyme of the pentose phosphate pathway (PPP), a branch of glycolysis, that converts glucose-6-phosphate (G6P) into...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
